| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.3 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.26 | 0.4 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |